Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Phase Genomics
AddedFeb 15, 2024
UpdatedJun 18, 2026
Phase Genomics

Phase Genomics

Series A

Seattle-based Phase Genomics, Inc., founded in 2015, specializes in commercial bio-physical research and development.

HQ
Seattle, WA, US
Founded
2015
Overview
Compare
Fundraising
Employees
Website

Phase Genomics, Inc., founded in 2015 and based in Seattle, specializes in commercial bio-physical research and development. The company offers ultra-long-range genome sequencing technology and computational tools designed to empower scientists in addressing pressing health and environmental challenges. Their products and services focus on cytogenetics, oncology, and metagenomics, enabling the identification and characterization of chromosomal abnormalities to better understand the genetic basis of cancer and inherited diseases.

Phase Genomics has made significant strides in transforming genomic discovery through its innovative technologies. By providing high-resolution assays, the company has contributed to advancements in understanding complex genetic conditions. Their impact is evident in the scientific community's ability to tackle critical health issues more effectively. Notable achievements include collaborations with leading research institutions and contributions to groundbreaking studies in genomics.

Phase Genomics - Similar Companies

Genome Insight logo

Genome Insight

Sequegenics logo

Sequegenics

sequegenics.com

Gencove logo

Gencove

gencove.com

Singular Genomics logo

Singular Genomics

Ultima Genomics logo

Ultima Genomics

ultimagenomics.com

Full Genomes logo

Full Genomes

fullgenomes.com

Bionano Genomics logo

Bionano Genomics

bionano.com

Genomenon logo

Genomenon

genomenon.com

ProPhase Labs logo

ProPhase Labs

prophaselabs.com

Genometry logo

Genometry

Base5 Genomics logo

Base5 Genomics

b5genomics.com

Paragon Genomics logo

Paragon Genomics

Streamline Genomics logo

Streamline Genomics

Lightspeed Genomics logo

Lightspeed Genomics

GenomeNext logo

GenomeNext

Phase Genomics - Quick Facts

Who are Phase Genomics' competitors?

Companies similar to Phase Genomics include Genome Insight, Sequegenics, Gencove and Singular Genomics.

When was Phase Genomics founded?

Phase Genomics was founded in 2015.

Where is Phase Genomics' headquarters located?

Phase Genomics' headquarters is located in Seattle, WA, US.

When was Phase Genomics' last funding round?

Phase Genomics' most recent funding round was for $5.5M (USD) in June 2022.

How much has Phase Genomics raised to-date?

As of Jun 9, 2022, Phase Genomics has raised a total of $15.3M (USD).

How many employees does Phase Genomics have?

Phase Genomics has 30 employees as of Feb 5, 2024.

Phase Genomics - Classification

Ownership
  • Private
  • Venture Capital
Technology
  • Biotech
  • Genomics
Geographic Exposure
  • Global
Revenue
  • Recurring
Main Product
  • Genome Sequencing
Tags
  • Biotech
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541714Research and Development in Biotechnology (except Nanobiotechnology)
  • 541000Professional, Scientific, and Technical Services
  • 541700Scientific Research and Development Services
  • 541710Research and Development in the Physical, Engineering, and Life Sciences
SIC
  • 8700Engineering, Accounting, Research, Management, And Related Services
  • 8730Research, Development, And Testing Services
  • 8731Commercial Physical and Biological Research
Show 15 more industry codes
NAICS
  • 513200Software Publishers
  • 541500Computer Systems Design and Related Services
  • 510000Information
  • 620000Health Care and Social Assistance
  • 513000Publishing Industries
  • 513210Software Publishers
  • 541510Computer Systems Design and Related Services
  • 541511Custom Computer Programming Services
SIC
  • 7300Business Services
  • 8000Health Services
  • 7370Computer Programming, Data Processing, And Other Computer Related
  • 8040Offices And Clinics Of Other Health Practitioners
  • 7371Computer Programming Services
  • 7372Prepackaged Software
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified